Bioliberty Ltd filed a Form D with the Securities and Exchange Commission on 2026-10-26.
Bioliberty Ltd filed a Form D notice of an exempt securities offering with the SEC on October 26, 2026. The filing reports $336K sold. Its industry group is Other Technology. It names Barry Hextall (Executive Officer), Rowan Armstrong (Director), Conan Bradley (Director) (SEC Form D, October 26, 2026).
Sell to companies like Bioliberty Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-26 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Bioliberty Ltd.
Free to see. No signup.
More on the people and the money behind Bioliberty Ltd, from the filings we hold.
Other Technology raises by companies based in the United Kingdom, filed in October 2026, largest first.
Get an email when Bioliberty Ltd files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Bioliberty Ltd raises, hires or launches. No email unless you switch it on.
Watch Bioliberty Ltd →Get the full cited report on Bioliberty Ltd
What the filing shows about Bioliberty Ltd
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Bioliberty Ltd: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Bioliberty Ltd →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 3831 filings in Other Technology, totalled by week. The dot is this raise, $336K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Barry Hextall is named as Executive Officer on the Form D that Bioliberty Ltd filed with the SEC on 26 October 2026, one of 10 people that filing names.
Rowan Armstrong is named as Director on the Form D that Bioliberty Ltd filed with the SEC on 26 October 2026, one of 10 people that filing names.
Conan Bradley is named as Director on the Form D that Bioliberty Ltd filed with the SEC on 26 October 2026, one of 10 people that filing names.
Shea Quinn is named as Director on the Form D that Bioliberty Ltd filed with the SEC on 26 October 2026, one of 10 people that filing names.
Ross O'Hanlon is named as Director on the Form D that Bioliberty Ltd filed with the SEC on 26 October 2026, one of 10 people that filing names.
Ramy El-Madany is named as Director on the Form D that Bioliberty Ltd filed with the SEC on 26 October 2026, one of 10 people that filing names.
David O'Reilly is named as Director on the Form D that Bioliberty Ltd filed with the SEC on 26 October 2026, one of 10 people that filing names.
Russell Bailey is named as Director on the Form D that Bioliberty Ltd filed with the SEC on 26 October 2026, one of 10 people that filing names.
Dana Strauss is named as Director on the Form D that Bioliberty Ltd filed with the SEC on 26 October 2026, one of 10 people that filing names.
Albert Nicholl is named as Director on the Form D that Bioliberty Ltd filed with the SEC on 26 October 2026, one of 10 people that filing names.
10 people named on the filing — 1 holding an executive role and 9 as directors only.
Named as of the 2026-10-26 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Bioliberty Ltd
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Bioliberty Ltd: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Bioliberty Ltd covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Bioliberty LtdYou get an alert in MentionFox the next time this company shows up.
If you're behind Bioliberty Ltd: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Bioliberty Ltd. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises, week of 2026-10-26
https://mentionfox.com/funding/bioliberty-ltd-form-d-000002